TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
Abstract Background Pancreatic cancer is a highly aggressive malignancy with limited treatment options and a poor prognosis. Trophoblast cell surface antigen 2 (TROP2), a cell surface antigen overexpressed in the tumors of more than half of pancreatic cancer patients, has been identified as a potent...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2023-11-01
|
| Ráidu: | Journal of Nanobiotechnology |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s12951-023-02183-9 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|